International Normalized Ratio and Prothrombin Time

Key Differences

The American College of Cardiology notes that PT is measured in seconds and represents the actual clotting time of plasma after adding thromboplastin and calcium, with values varying significantly depending on the specific thromboplastin reagent used and the measurement technique/instrument 1, 2
PT results are not interchangeable between laboratories using different reagents, making direct comparison unreliable, as stated by the American College of Cardiology 3
The International Normalized Ratio (INR) is a calculated, standardized value derived from the PT using a specific formula, providing equivalence between various reagents and techniques, according to the American College of Cardiology 1, 4, 3

The American College of Cardiology emphasizes that INR is NOT the same as PT ratio, which is a common source of confusion, with the PT ratio being simply the patient's PT divided by a normal control PT, without the ISI correction factor that makes the INR standardized 3, 5

The American College of Cardiology recommends always overlapping heparin with warfarin for at least 4-5 days until the INR is therapeutic, regardless of early INR elevation, because true anticoagulation requires Factor II depletion 6
The American College of Cardiology advises never discontinuing heparin based solely on an elevated INR in the first 72-96 hours of warfarin therapy 6
Once steady-state is achieved (after 4-6 days), the INR becomes a reliable indicator as all vitamin K-dependent factors reach equilibrium, according to the American College of Cardiology 6
The American College of Cardiology states that INR was designed specifically for warfarin monitoring based on patients on stable anticoagulation for at least 6 weeks 3
There is no high-quality evidence supporting INR targets or plasma transfusion for mildly elevated INR (1.0-2.0 range) in patients not on vitamin K antagonists, as noted by the Journal of Thrombosis and Haemostasis 7

The PT ratio was first introduced in 1941 by Karl Link and colleagues as “the ratio of the logarithm of clotting times” to assess impaired coagulation in animal models (rabbits fed sweet‑clover hay)【8】.
Early clinical case reports from the 1940s indicated that a PT ratio between 1.5 and 3.0 was associated with adequate anticoagulation when patients were treated with the vitamin K antagonist dicoumarol【8】.

Because PT results depend on the specific thromboplastin reagent used, PT values were not interchangeable between laboratories; this variability contributed to both excessive bleeding and breakthrough clotting in patients receiving anticoagulants【8】.
Using the PT ratio to compare anticoagulation status across different laboratories is therefore unreliable and constitutes a common error in practice【8】.

The International Normalized Ratio (INR) is a standardized metric specifically designed for monitoring vitamin K antagonist therapy (e.g., warfarin); it incorporates the International Sensitivity Index (ISI) to correct for reagent‑dependent differences【9】.
In contrast, the PT ratio lacks the ISI correction factor, is not standardized, and therefore should not be used as a substitute for INR when managing patients on vitamin K antagonists【9】.